… measured plasma tranexamic acid concentrations in 21 patients receiving tranexamic acid
prophylaxis according to our standard protocol for primary cardiac surgery with CPB. Our goal …

… Tranexamic acid (TA) reduces blood loss and blood transfusion during heart surgery with
cardiopulmonary bypass (CPB). TA dosing has been empiric because only limited …

… early seizure after cardiopulmonary bypass (CPB) were examined. The role of tranexamic
acid in … Current guidelines make a class I recommendation for tranexamic acid use as a blood-…

… complications of cardiac surgery is excessive … by cardiopulmonary bypass (CPB) during
and after cardiac surgery. Therefore, antifibrinolytic agents are used during cardiac surgery with …

… cardiopulmonary bypass. One hundred fifty patients scheduled to undergo cardiac operations
with cardiopulmonary bypass were … The first group received 10 gm of tranexamic acid …

… of high-dose tranexamic acid for 24 h after administration of the drug in patients undergoing
cardiac surgery with cardiopulmonary bypass. High-dose tranexamic acid involved a bolus …

… undergoing cardiopulmonary bypass for … of tranexamic acid (total dose 20 mg/kg body
weight, n =15), and nonmedicated controls (n =14) during 24 hours after cardiopulmonary bypass. …

… artery bypass surgery (CABG) using cardiopulmonary bypass (… Perioperative use of tranexamic
acid (TA), a synthetic … patients receiving blood transfusions in cardiac surgery. In addition, …

… Group TA (N = 20 ) received tranexamic acid as an intravenous loading dose of 15 mg/kg,
followed by a continuous infusion of 1 mg/kg per hour for 6 hours. The control group (N = 19) …

… tranexamic acid (TA) has grown since the widespread removal of aprotinin, but its dosing
during cardiac surgery … in adult cardiac surgery patients during cardiopulmonary bypass (CPB). …